Bg pattern

TRAVATAN 40 micrograms/ml eye drops, solution

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use TRAVATAN 40 micrograms/ml eye drops, solution

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

TRAVATAN 40 micrograms/ml eye drops, solution

travoprost

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What TRAVATAN is and what it is used for
  2. What you need to know before you use TRAVATAN
  3. How to use TRAVATAN
  4. Possible side effects
  5. Storage of TRAVATAN
  6. Contents of the pack and other information

1. What TRAVATAN is and what it is used for

TRAVATAN contains travoprostwhich belongs to a group of medicines called prostaglandin analogues. It works by reducing the pressure in the eye. It can be used on its own or with other eye drops that reduce pressure in the eye, for example beta blockers.

TRAVATAN is used to reduce high pressure in the eye in adults, adolescents and children from 2 months of age. This pressure can lead to a condition called glaucoma.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use TRAVATAN

Do not use TRAVATAN

  • If you are allergic to travoprost or any of the other ingredients of this medicine (listed in section 6).

Tell your doctor if you are in this situation.

Warnings and precautions

  • TRAVATAN may increasethe length, thickness, color and/or number of your eyelashes. Unusual changes to the hair on your eyelids or the skin around your eye have also been seen.
  • TRAVATAN may change the color of your iris(the colored part of your eye). This change may be permanent. It may also cause a change in the color of the skin around your eye.
  • If you have had cataract surgery, talk to your doctor before using TRAVATAN.
  • If you have eye inflammation(uveitis and iritis), talk to your doctor before using TRAVATAN.
  • TRAVATAN may, in rare cases, cause shortness of breathor wheezingor increase the symptoms of asthma. If you are concerned about changes to your breathing while using TRAVATAN, talk to your doctor as soon as possible.
  • Travoprost may be absorbed through the skin. If the medicine comes into contact with the skin, it should be washed off immediately. This is especially important for women who are pregnant or trying to become pregnant.
  • If you wear soft contact lenses, do not apply the drops while wearing them. Wait 15 minutes after applying the drops before putting your lenses back in.

Children and adolescents

TRAVATAN can be used in children from 2 months to less than 18 years of age at the same dose as in adults. TRAVATAN is not recommended for use in children under 2 months of age.

Other medicines and TRAVATAN

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

Pregnancy, breast-feeding and fertility

Do not use TRAVATAN if you are pregnant. If you could be pregnant, tell your doctor. If you can become pregnant, use a suitable method of contraception while using TRAVATAN.

Do not use TRAVATAN if you are breast-feeding. TRAVATAN may pass into breast milk.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Immediately after applying TRAVATAN you may feel a slight burning sensation in your eye or your vision may become blurred for a short time. Do not drive or use machines until your vision is clear.

TRAVATAN contains hydrogenated castor oil and propylene glycol, which may cause skin reactions or irritation.

3. How to use TRAVATAN

Use this medicine exactly as your doctor or the doctor treating the child has told you. If you are not sure, ask your doctor or pharmacist.

The recommended dose is

One drop in the affected eye(s) once a day, in the evening.

Only use TRAVATAN in both eyes if your doctor has told you to do so. Continue the treatment for as long as your doctor or the doctor treating the child has told you to.

Two fingers holding a small white oval-shaped capsule with concentric lines

Application of eye drops with a finger pulling down the lower eyelid and a dropper near the eye

Hand holding an injection device with a connected needle and a drop hanging from the tip

Head profile showing nasal application with a white spray pointing towards the nasal cavity

TRAVATAN should only be used as eye drops.

  • Just before using a bottle for the first time, open the protective sleeve, take out the bottle and write the date you opened it on the space provided on the carton.
  • Wash your hands.
  • Remove the cap.
  • Hold the bottle upside down between your fingers.
  • Tilt your head or the child’s head back and gently pull the lower eyelid down to create a pocket, where the drop can fall (figure 2).
  • Bring the bottle tip close to the eye. You may find it easier to do this in front of a mirror.
  • Do not touch the eye, eyelid, or surrounding areas with the dropperbecause the drops could become contaminated.
  • Gently squeeze the bottle to release one drop at a time (figure 3).
  • After using TRAVATAN, gently close your eyes and press the inner corner of your eye with your finger for about 1 minute (figure 4). This helps prevent TRAVATAN from entering the rest of your body.
  • If you are applying drops to both eyes, repeat the steps for the other eye.
  • Close the bottle tightly after use.
  • Use one bottle at a time. Do not open the protective sleeve until you are ready to use the bottle.

If a drop falls outside the eye, try again.

If you are using other eye medicines, such as eye drops or ointments, wait at least 5 minutes between applying TRAVATAN and the other medicine.

If you use more TRAVATAN than you should

Flush your eyes with lukewarm water. Do not apply more drops until your next normal dose.

If you forget to use TRAVATAN

Carry on with the next dose as planned. Do not apply a double doseto make up for a forgotten dose. Never apply more than one drop in the affected eye(s) in a single day.

If you stop using TRAVATAN

Do not stop using TRAVATAN without talking to your doctor or the doctor treating the child first. The pressure in your eye or the child’s eye will not be controlled, which could lead to loss of vision.

If you have any other questions on the use of this medicine, ask your doctor or pharmacist.

Continue

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

You can normally continue with your treatment. If the side effects are severe, talk to your doctor or pharmacist. Do not stop using TRAVATAN without talking to your doctor.

The following side effects have been seen with TRAVATAN:

Very common: may affect more than 1 in 10 people

Eyes:redness of the eye.

Common: may affect up to 1 in 10 people

Eyes:change in iris color (the colored part of the eye), eye pain, discomfort in the eye, dry eye, itching of the eye, irritation of the eye.

Uncommon: may affect up to 1 in 100 people

Eyes:corneal changes, inflammation of the eye, inflammation of the iris, inflammation inside the eye, inflammation with or without damage to the surface of the eye, sensitivity to light, discharge from the eye, inflammation of the eyelid, redness of the eyelid, swelling around the eye, itching of the eyelid, blurred vision, increased tear production, infection or inflammation of the conjunctiva (conjunctivitis), abnormal turning out of the lower eyelid, darkened vision, crusts on the eyelid, growth of eyelashes.

Other effects:increase in allergic symptoms, headache, irregular heartbeat, cough, blocked nose, sore throat, darkening of the skin around the eyes, darkening of the skin, abnormal hair texture, excessive hair growth.

Rare: may affect up to 1 in 1,000 people

Eyes:seeing flashes of light, eczema of the eyelids, abnormally positioned eyelashes that grow towards the eye, swelling of the eye, reduced vision, seeing halos around lights, decreased sensation in the eye, inflammation of the eyelid glands, pigmentation inside the eye, increase in pupil size, thickening of eyelashes, change in eyelash color, tired eyes.

Other effects:viral infection of the eye, dizziness, bad taste, irregular or slow heartbeat, increased or decreased blood pressure, shortness of breath, asthma, nasal inflammation or allergy, dry nose, changes in voice, stomach ulcers or discomfort, constipation, dry mouth, redness or itching of the skin, rash, change in hair color, loss of eyelashes, joint pain, muscle pain, general weakness.

Frequency not known: cannot be estimated from the available data

Eyes:inflammation of the back of the eye, sunken eyes.

Other effects:depression, anxiety, insomnia, feeling of false movement, ringing in the ears, chest pain, irregular heartbeat, increased heart rate, worsening of asthma, diarrhea, nosebleeds, abdominal pain, nausea, vomiting, itching, abnormal hair growth, painful or involuntary urination (painful or involuntary passing of urine), increase in prostate cancer marker.

In children and adolescents, the most common side effects seen with TRAVATAN are redness of the eye and growth of eyelashes. Both side effects were seen more often in children and adolescents compared to adults.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of TRAVATAN

Keep this medicine out of the sight and reach of children.

Do not use TRAVATAN after the expiry date which is stated on the bottle and the carton after “EXP”. The expiry date is the last day of the month shown.

This medicine does not require any special storage conditions.

To avoid infections, you must throw away the bottle 4 weeks after you first opened itand use a new bottle. Write the date you opened it on the space provided on the carton.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to throw away medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

What TRAVATAN contains

The active substance is travoprost 40 micrograms/ml.

The other ingredients are: Polyquaternium-1, hydrogenated castor oil, propylene glycol, sodium chloride, boric acid, mannitol, and purified water. Small amounts of hydrochloric acid or sodium hydroxide may be added to keep the levels of acidity (pH levels) normal.

Appearance and packaging

TRAVATAN is a liquid (a clear, colorless solution) which comes in a carton containing a 4 ml plastic bottle with a screw cap. Each bottle contains 2.5 ml of travoprost eye drops and each bottle is enclosed in a protective sleeve.

Pack sizes: 1 or 3 bottles.

Not all pack sizes may be marketed.

Marketing authorisation holder

Novartis Europharm Limited

Vista Building

Elm Park, Merrion Road

Dublin 4

Ireland

Manufacturer

Novartis Farmacéutica, S.A.

Gran Via de les Corts Catalanes, 764

08013 Barcelona

Spain

Novartis Manufacturing NV

Rijksweg 14

2870 Puurs-Sint-Amands

Belgium

Novartis Pharma GmbH

Roonstraße 25

D-90429 Nuremberg

Germany

Siegfried El Masnou, S.A.

Camil Fabra 58

El Masnou

08320 Barcelona

Spain

Novartis Pharma GmbH

Sophie-Germain-Strasse 10

90443 Nürnberg

Germany

You can get more information on this medicine from your local representative of the marketing authorisation holder:

België/Belgique/Belgien

Novartis Pharma N.V.

Tél/Tel: +32 2 246 16 11

Lietuva

SIA Novartis Baltics Lietuvos filialas

Tel: +370 5 269 16 50

Text with the company name Novartis Bulgaria Eood and their phone number +359 2 489 98 28 on a white background

Luxembourg/Luxemburg

Novartis Pharma N.V.

Tél/Tel: +32 2 246 16 11

Ceská republika

Novartis s.r.o.

Tel: +420 225 775 111

Magyarország

Novartis Hungária Kft.

Tel.: +36 1 457 65 00

Danmark

Novartis Healthcare A/S

Tlf: +45 39 16 84 00

Malta

Novartis Pharma Services Inc.

Tel: +356 2122 2872

Deutschland

Novartis Pharma GmbH

Tel: +49 911 273 0

Nederland

Novartis Pharma B.V.

Tel: +31 88 04 52 111

Eesti

SIA Novartis Baltics Eesti filiaal

Tel: +372 66 30 810

Norge

Novartis Norge AS

Tlf: +47 23 05 20 00

Ελλáδα

Novartis (Hellas) A.E.B.E.

Τηλ: +30 210 281 17 12

Österreich

Novartis Pharma GmbH

Tel: +43 1 86 6570

España

Novartis Farmacéutica, S.A.

Tel: +34 93 306 42 00

Polska

Novartis Poland Sp. z o.o.

Tel.: +48 22 375 4888

France

Novartis Pharma S.A.S.

Tél: +33 1 55 47 66 00

Portugal

Novartis Farma - Produtos Farmacêuticos, S.A.

Tel: +351 21 000 8600

Hrvatska

Novartis Hrvatska d.o.o.

Tel. +385 1 6274 220

România

Novartis Pharma Services Romania SRL

Tel: +40 21 31299 01

Ireland

Novartis Ireland Limited

Tel: +353 1 260 12 55

Slovenija

Novartis Pharma Services Inc.

Tel: +386 1 300 75 50

Ísland

Vistor hf.

Sími: +354 535 7000

Slovenská republika

Novartis Slovakia s.r.o.

Tel: + 421 2 5542 5439

Italia

Novartis Farma S.p.A.

Tel: +39 02 96 54 1

Suomi/Finland

Novartis Finland Oy

Puh/Tel: +358 (0)10 6133 200

Κúπρος

Novartis Pharma Services Inc.

Τηλ: +357 22 690 690

Sverige

Novartis Sverige AB

Tel: +46 8 732 32 00

Latvija

SIA Novartis Baltics

Tel: +371 67 887 070

Date of last revision of this leaflet

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu

Online doctors for TRAVATAN 40 micrograms/ml eye drops, solution

Discuss questions about TRAVATAN 40 micrograms/ml eye drops, solution, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for TRAVATAN 40 micrograms/ml eye drops, solution?
TRAVATAN 40 micrograms/ml eye drops, solution requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in TRAVATAN 40 micrograms/ml eye drops, solution?
The active ingredient in TRAVATAN 40 micrograms/ml eye drops, solution is travoprost. This information helps identify medicines with the same composition but different brand names.
How much does TRAVATAN 40 micrograms/ml eye drops, solution cost in pharmacies?
The average pharmacy price for TRAVATAN 40 micrograms/ml eye drops, solution is around 13.35 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures TRAVATAN 40 micrograms/ml eye drops, solution?
TRAVATAN 40 micrograms/ml eye drops, solution is manufactured by Novartis Europharm Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of TRAVATAN 40 micrograms/ml eye drops, solution online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether TRAVATAN 40 micrograms/ml eye drops, solution is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to TRAVATAN 40 micrograms/ml eye drops, solution?
Other medicines with the same active substance (travoprost) include LEACHIM 40 MICROGRAMS/ML EYE DROPS IN SOLUTION, SINETRAV 40 MICROGRAMS/ML EYE DROPS SOLUTION, TAVLIANT 40 micrograms/ml eye drops solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media